Prudential Financial’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,417
| Closed | -$27.6K | – | 2768 |
|
|
2024
Q1 | $27.6K | Buy |
1,417
+287
| +25% | +$5.6K | ﹤0.01% | 2636 |
|
|
2023
Q4 | $23.4K | Hold |
1,130
| – | – | ﹤0.01% | 2608 |
|
|
2023
Q3 | $35.9K | Sell |
1,130
-220
| -16% | -$7K | ﹤0.01% | 2533 |
|
|
2023
Q2 | $45.4K | Buy |
1,350
+203
| +18% | +$6.82K | ﹤0.01% | 2543 |
|
|
2023
Q1 | $47.8K | Hold |
1,147
| – | – | ﹤0.01% | 2501 |
|
|
2022
Q4 | $38.9K | Buy |
1,147
+247
| +27% | +$8.37K | ﹤0.01% | 2518 |
|
|
2022
Q3 | $44K | Hold |
900
| – | – | ﹤0.01% | 2565 |
|
|
2022
Q2 | $35K | Buy |
900
+556
| +162% | +$21.6K | ﹤0.01% | 2599 |
|
|
2022
Q1 | $13K | Buy |
+344
| New | +$13K | ﹤0.01% | 2590 |
|
|
2021
Q4 | – | Sell |
-1,391
| Closed | -$174K | – | 2685 |
|
|
2021
Q3 | $174K | Buy |
+1,391
| New | +$174K | ﹤0.01% | 2497 |
|